Information Provided By:
Fly News Breaks for March 21, 2016
ENDP
Mar 21, 2016 | 10:54 EDT
JPMorgan analyst Chris Schott views shares of Endo International as attractive for investors with a longer term outlook, as he expects the stock's recovery to be gradual given a lack of near-term catalysts and "bearish sentiment across the space." Schott calls Endo's Q1 update last week disappointing and lowered his price target for the shares to $65 from $80. He keeps an Overweight rating on the name. Endo is seeing weakness in a "relatively small portion" of its business, Schott tells investors in a research note.
News For ENDP From the Last 2 Days
There are no results for your query ENDP